Adam C. Vandervoort - 04 Mar 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort
Issuer symbol
TDOC
Transactions as of
04 Mar 2022
Net transactions value
-$258,873
Form type
4
Filing time
08 Mar 2022, 15:11:36 UTC
Previous filing
04 Mar 2022
Next filing
03 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +3,454 +44% 11,371 04 Mar 2022 Direct F1
transaction TDOC Common Stock Options Exercise +4,491 +39% 15,862 04 Mar 2022 Direct F2
transaction TDOC Common Stock Sale $258,873 -3,879 -24% $66.74 11,983 07 Mar 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -3,454 -100% $0.000000* 0 04 Mar 2022 Common Stock 3,454 Direct F1, F4
transaction TDOC Performance Stock Units Options Exercise $0 -4,491 -100% $0.000000* 0 04 Mar 2022 Common Stock 4,491 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
F4 On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F5 On February 26, 2020, the reporting person earned 13,471 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020.